As of November 6, 2026, Adlai Nortye Ltd. is a publicly traded company (Nasdaq: ANL); its largest reported holder is ANL Talent Limited, with 7.75% on Schedule 13G of January 16, 2026, then Cormorant Asset Management, LP (6.77%). The largest insider holding is Birgerson Lars Erik, a director, with 166,668 shares, per Form 3 of August 4, 2026 (Schedule 13G, January 16, 2026).
Is this your company?
About to sign with, pay or invest in Adlai Nortye Ltd.? See the free Snapshot first.
Free to see. No signup.
Is Adlai Nortye Ltd. a real, registered company?
- Adlai Nortye Ltd. files with the SEC under CIK 1944552 (its SEC filings).
- Its shares are listed under the ticker ANL on Nasdaq (SEC company record).
- Incorporated in Delaware, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Adlai Nortye Ltd. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Cormorant Asset Management, LP (filed 2026-08-14).
Who are Adlai Nortye Ltd.'s owners and officers?
Adlai Nortye Ltd.: incorporated in Delaware; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Venrock Healthcare Capital Partners Iii, L.P. | 4.4% |
| Schedule 13G/A, 2026-08-14 | Cormorant Asset Management, LP | 6.77% |
| Schedule 13G, 2026-05-15 | Cormorant Asset Management, LP | 5.19% |
| Schedule 13G/A, 2026-05-14 | Jin Yin (Bvi) Limited | 2.9% |
| Schedule 13G, 2026-02-11 | Venrock Healthcare Capital Partners Iii, L.P. | 6.1% |
| Schedule 13G/A, 2026-02-09 | Unique Mark Ventures LTD | 0% |
| Schedule 13G, 2026-01-20 | Unique Mark Ventures LTD | 6.14% |
| Schedule 13G, 2026-01-16 | Anl Talent Limited | 7.75% |
Questions about who owns Adlai Nortye Ltd.
Who owns Adlai Nortye Ltd.?
On this page, 2 holders' latest ownership filings report 5% or more of Adlai Nortye Ltd.: Anl Talent Limited (7.75%, Schedule 13G, filed 2026-01-16) and Cormorant Asset Management, LP (6.77%, Schedule 13G/A, filed 2026-08-14).
Who are the largest shareholders of Adlai Nortye Ltd.?
By the share each holder's latest filing reports, the largest holders of Adlai Nortye Ltd. on this page are Anl Talent Limited (7.75%) and Cormorant Asset Management, LP (6.77%).
When did Anl Talent Limited buy into Adlai Nortye Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Anl Talent Limited on this page is the Schedule 13G, filed 2026-01-16, reporting 7.75%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Adlai Nortye Ltd.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Adlai Nortye Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Adlai Nortye Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Adlai Nortye Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 166,668 shares (Form 3, 2026-08-04).
- , the chief financial officer: 147,757 shares (Form 4, 2026-08-26).
- , a director: 121,453 shares (Form 4, 2026-10-01).
- , the chief executive and a director: 99,990 shares (Form 4, 2026-05-21).
- , a director: 9,838 shares (Form 3, 2026-07-15).
Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.
How much has Adlai Nortye Ltd. raised?
No fundraising or offering filing from Adlai Nortye Ltd. is on file with us.
Keep reading
More on Adlai Nortye Ltd. and the records around it.
Adlai Nortye Ltd. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Cormorant Asset Management, LP also filed stake reports on 17 other companies: Corbus Pharmaceuticals Holdings, Inc. (Nov 2026), BioAge Labs, Inc. (Aug 2026), Bright Minds Biosciences Inc. (Aug 2026)
- Venrock Healthcare Capital Partners III, L.P. also filed stake reports on 34 other companies: Entera Bio Ltd. (Oct 2026), Lycia Therapeutics, Inc. (Oct 2026), Frazier Life Sciences Acquisition Corp. II (Oct 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/adlai-nortye